InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Simson Jake. Director active across 1 company, notably Janux Therapeutics, Inc.. In total, 1 reports have been published. History available since 26 June 2024. The latest transaction was disclosed on 26 June 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration